17 May 2023
Selecting the right first valve to secure lifetime management
Sponsored by Boston Scientific
Anchorperson:
D. Mylotte
Spokesperson:
H. Möllmann
Summary
The treatment of young and less at-risk patients clearly shows that their age, life expectancy and risk factors are essential parameters to be taken into account in the choice of TAVI and therefore it is essential to think about future coronary access after TAVI. Watch the video and find out about the key points to be considered.
Learning Objectives
- To understand the impact of age, life expectancy, and risk profile on TAVI choice
- To master future coronary access after TAVI
- To discuss the role of transcatheter heart valve design in TAVI durability and future TAV-in-TAV options
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide005.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)
/slide015.jpg)
/slide016.jpg)
/slide017.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)